The global endotracheal tube market size was worth US$ YY million in 2020 and is forecasted to reach US$ YY million by 2028, at a CAGR of 6.30% during the forecast period.
An endotracheal tube is a flexible plastic tube that is placed through the mouth into the trachea which is connected to a ventilator to deliver oxygen to the lungs. The tube is inserted when a patient is unable to breathe on their own. The process of inserting the tube is called endotracheal intubation. Endotracheal tubes are mostly made of polyvinyl chloride (PVC) and can be used only once.
Download free sample @ https://bit.ly/3JfI0Mq
Patients suffering from infectious, and cardiac conditions often experience airway complications, which require immediate treatment. Similarly, road accident victims and people suffering from other trauma injuries may require immediate airway clearance to ensure their safety.
A prominent reason for the increasing prevalence of respiratory diseases is air pollution. According to the WHO Report 2019, around 2 billion people globally are exposed to indoor toxic air, 1 billion people are exposed to outdoor pollutant air, and around 1 billion people are exposed to tobacco smoke.
By Product Type
By Intubation Type
Market Segmentation – By Product Type – Double Lumen Endotracheal Tube
The most common technique for lung separation is the placement of a double-lumen endotracheal tube (DLT). The lungs are paired organs connected by bronchi and trachea that work together as a unit.
Certain surgical procedures within the thoracic cavity, such as operations on the lung tissue, oesophagus, mediastinal structures, thoracic vasculature, and thoracic spine, may necessitate isolating one side from the other. Furthermore, lung isolation allows for the treatment of certain lung pathologies such as unilateral lung haemorrhage, infection, trauma, bullous disease, or bronchopleural fistula.
COVID 19 IMPACT ANALYSIS
COVID-19 has positively impacted the global endotracheal tube market with increased demand for use of endotracheal tubes in coronavirus infected population
The severity of COVID-19 infection varied from asymptotic to critically ill resulting in acute hypoxemic respiratory insufficiency. These patients underwent emergency treatment through ventilation therapies. Also, the infected and recovered population have reportedly developed poor oxygenation, Acute respiratory distress syndrome (ARDS) and cardiac arrest. Thus, the demand for endotracheal tubes increased significantly during the pandemic.
Geographical Analysis – North America
Due to the high number of such cases, the demand for airway management devices is increasing across the globe. According to the 2019 health data of CDC, the number of emergency department visits among adults aged 18 years and above in the US has increased by about 8.67% during 1997-2018.
Recently increasing occurrence of Ventilator-associated Pneumonia (VAP) is most widely seen in patients who are on the endotracheal tube or mechanical ventilator for more than 48 hours.
Thus, many players in the market are developing products with antimicrobial coating and anti-coagulant coating properties which can reduce VAP. For example, Medtronic Shiley Evac endotracheal tubes have been stated to reduce the VAP by 50.0%.
View full report @ https://bit.ly/3KJNC1N
The global endotracheal tube market is moderately competitive in nature, with the leading players capturing a whopping share in revenues. ConvaTec Inc., Bactiguard AB, Teleflex Incorporated, Medtronic Plc., Smiths Group plc.(Smiths Medical), ROYAX, S.R.O, Medline Industries, Inc., Eakin Healthcare Group(Armstrong Medical Ltd), Venner Medical, P3 Medical Limited among others, are focused on technology advances for new launches at affordable price points, to remain ahead of the curve.
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States